Details for New Drug Application (NDA): 021719
✉ Email this page to a colleague
NDA 021719 describes ARICEPT, which is a drug marketed by Eisai Inc and is included in four NDAs. It is available from one supplier. There is one patent protecting this drug and two Paragraph IV challenges. Additional details are available on the ARICEPT profile page.
The generic ingredient in ARICEPT is donepezil hydrochloride. There are thirty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride profile page.
The generic ingredient in ARICEPT is donepezil hydrochloride. There are thirty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride profile page.
Summary for 021719
| Tradename: | ARICEPT |
| Applicant: | Eisai Inc |
| Ingredient: | donepezil hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 5MG/5ML | ||||
| Approval Date: | Oct 18, 2004 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
